Posted inBiotechnology
Revolutionary ‘True Food’ Research Database Ranks 50,000 Processed Foods
A groundbreaking project originating from Mass General Brigham is set to transform the way consumers and policymakers understand processed foods.…
Posted inBiotechnology
Unraveling the Mystery: The Mechanism Behind Tumor Cell Death Post-Radiotherapy
Scientists at the Children’s Medical Research Institute (CMRI) have uncovered critical insights that answer a long-standing question in cancer research…
Posted inBiotechnology
Blood-Based Tumor DNA Analysis Offers New Insights into Lung Cancer Prognosis
A groundbreaking study conducted by renowned scientists from the Francis Crick Institute alongside UCL, UCLH, and Personalis has unveiled a…
Posted inBiotechnology
Evolutionary Map Reveals Key Genes for Bacterial Survival
The complex interactions between humans and the bacterium Staphylococcus aureus have long intrigued scientists, especially considering its dual role in…
Posted inBiotechnology
Groundbreaking Research Sheds Light on the Mysteries of Cosmic Particle Accelerators
Scientists are unraveling the mysteries of collisionless shock waves, a phenomenon that pervades the cosmos and serves as one of…
Posted inBiotechnology
Kailera reports Zepbound-rivaling weight loss in phase 2 obesity trial
Fresh from a $400 million series A round, Kailera Therapeutics has shown off phase 2 data on an obesity candidate it…
Posted inBiotechnology
JPM25: AbbVie pens $1B deal for Simcere’s phase 1 T-cell engager
T-cell engagers have been hot property in recent months, so it’s only right that one the biggest deals to kick…
Posted inBiotechnology
JPM25: Eli Lilly strikes $2.5B Scorpion buyout in twist to breast cancer tale
Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan…
Posted inBiotechnology
Exploring the Impact of Obesity on Childhood Cancer Survival Rates
A groundbreaking retrospective study published in the esteemed journal CANCER reveals concerning data regarding childhood cancer patients who are obese…
Posted inBiotechnology
Telix continues shopping spree with $45M purchase of ImaginAb’s preclinical drugs, facility
Telix Pharmaceuticals’ expansion phase shows no sign of running out yet, with the Australian radiopharma company paying $45 million in…